SRAX Inc.’s (NASDAQ: SRAX) BIGtoken Platform Numbers 16

New Post Public Reply Private Reply Replies (0) Message Board
NetworkNewsWire
145
SRAX Inc.’s (NASDAQ: SRAX) BIGtoken Platform Numbers 16 Million-Plus as Consumers Respond to Opt-In Data Management

- To date, more than 16 million consumers around the world have joined; that number increases daily
- SRAX offers other powerful data-management tools

SRAX Inc. (NASDAQ: SRAX), a digital marketing and consumer data management technology company, has had more than 16 million consumers opt-in to its BIGtoken consumer-managed data platform since the product was released earlier this year. In addition, SRAX offers other powerful products designed to provide marketers and consumers with the tools to unlock the value of data.

During an interview at SNNLive at the Planet MicroCap Showcase 2019 in Las Vegas, SRAX CEO and co-founder Christopher Miglino was asked about the “secret sauce” to getting such a high response rate (http://nnw.fm/nO9rz). Miglino noted that the budget for the launch was $2 million, but the company started with a modest $20,000. “We spent twenty grand, and the thing went completely viral,” he said. “People started signing up all over the place. We were having around 700,000 invites a day going out through the platform, so people were inviting 700,000 a day to the platform… If you go to social media even today and you pull up Twitter and YouTube and Instagram, and type in BIGtoken, you’ll see thousands of posts, thousands of consumer engagements from people talking about how they love the platform.”

From that impressive start, BIGtoken has grown into an exclusive platform with more than 16 million opted-in consumers around the world. “BIGtoken is unique in the data set it has gathered, the way it rewards consumers who have opted in and the manner it provides access to that data to marketers,” Miglino observed. “Consumers are becoming much more aware of their own privacy. A few years ago, people didn’t care, but now all of a sudden, consumers are realizing that their data is worth a lot of money. We’re working very hard to create an environment where consumers own that data on their own, and when anybody wants to access that data, they are monetizing the issue.”

In addition to BIGtoken, SRAX provides other valuable technology tools that unlock data to reveal brands’ core consumers across marketing channels. Those tools include the following:

SRAX Core allows users to integrate inventory and reporting from all vendors, channels and formats in one dashboard; build and save custom data segments in seconds; and gain deep insights into campaign optimization with a dedicated single point of contact;
SRAX IR allows users to discover insights about their shareholders and market makers and their contributions to the company; manage and monitor ROI from investor relations firms; grow shareholder base with precise audience-building, targeting and delivery across programmatic and social channels; and save new contacts from investor events and provide them collateral within the platform;
SRAX Auto allows users to use first-party data to ensure their brand is top of mind when known car buyers lease again; track and target test drivers and visitors to specific dealerships; link direct-mail programs to online ad targeting; and
SRAX Shopper allows users to influence shoppers at the pivotal place and time with intent-based geotargeting; drive in-store foot traffic and purchases; and deliver personalized shopper-ad experiences.
Based in Los Angeles, SRAX is a digital-marketing and data-management technology company focused on building the largest and most valuable opted-in data set in the world. The company provides marketers, content owners and consumers with proprietary tools to unlock the value of that data. SRAX technology also unlocks data to reveal brands core consumers and their characteristics across marketing channels. SRAX delivers a digital competitive advantage for brands in the healthcare, CPG, automotive, sports and lifestyle verticals.

For more information, visit the company’s website at www.SRAX.com

Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

SRAX Inc. (SRAX) Stock Research Links

SRAX Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

MRI Surveillance Gains Ground in Lung Cancer Care

Updated Category News Views 6

Shifting the Standard: MRI's Rise in SCLC Treatment Here's a twist that baffles the traditionalists—ditch the prophylactic cranial irradiation (PCI) and catch clearer days with MRI surveillance for small-cell lung cancer (SCLC). The latest international phase III MAVERICK trial might just redraw the lines on what's considered standard care in this relentless disease....

Continue Reading
GORGIE Unleashes Berry Burst: Target's New Drink Star

Updated Category News Views 5

GORGIE Targets Taste Buds with Berry Burst Ever feel like you're missing out on that energy drink everyone seems to be raving about? Well, GORGIE's out there making some noise again, and this time it's got a new punchy player in the game: Berry Burst. It's not just another drink; it's shaking things up in the energy aisle with its exclusive launch at Target. Modern style...

Continue Reading
UWM Faces Class Action Deadline: Key Insights for Investors

Updated Category News Views 2

The High Stakes Reality for UWM Investors If there's one thing that's certain in this jittery world of investing, it's that losses have a way of waking you up. Right now, anyone tied up with UWM Holdings Corporation (NYSE: UWMC) shares needs to keep their wits about them; we're barreling toward an October 13, 2026 deadline for a class action lawsuit. The clock's ticking...

Continue Reading
PwC US and India Unite for Global Consultancy Powerhouse

Updated Category News Views 6

Rearranging the Consultancy Chessboard Piling onto the game of consultancy realignments, PwC just made a move reminiscent of playing strategy poker. They're tossing together PwC US and PwC India's advisory capabilities for a new joint venture. It’s like pushing two puzzle pieces to make a single colorful picture that stretches from the U.S. all the way to the...

Continue Reading
Regeneron Faces Legal Heat: Lead Plaintiff Deadline Looms

Updated Category News Views 3

Regeneron’s Tight Spot: Legal Showdown Well, here we go again—Regeneron Pharmaceuticals (NASDAQ:REGN) is under some serious heat. If you're an investor who faced significant losses with this biotech juggernaut, remember that the clock’s ticking down to the wire. By tomorrow, September 14, 2026, you need to decide if you're going to throw your hat in the ring for...

Continue Reading
Surfing Dogs Ride Waves, Support Orphan Pets

Updated Category News Views 3

Waves, Paws, and Passion Who would've thought that dogs catching waves could also catch hearts and wallets? Well, that's exactly what's happening today at Del Mar Dog Beach with the 21st Annual Surf Dog Surf-A-Thon revving up the excitement. It's a sun-soaked day in Rancho Santa Fe, California, right in the thick of things at the longest-running dog surf competition. For...

Continue Reading
First-Time Homeowners: Unseen Pitfalls of Insurance

Updated Category News Views 2

Understanding Homeowners Insurance: Beyond the Basics Most folks diving into homeownership for the first time get caught up in the whirlwind of price tags, loans, and knick-knacks for their new place. Meanwhile, the nitty-gritty of homeowners insurance often gets tossed to the side. But take it from a weary watchdog of financial storms—it’s those details in the policy...

Continue Reading
Trial Disappointment: No Significant Gains in NSCLC

Updated Category News Views 8

Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...

Continue Reading
PANDAG G1 Debuts: Revolutionizing Lawn Care Efficiency

Updated Category News Views 4

The Future of Landscaping Unveiled Get this—PANDAG is set to shake things up at GaLaBau 2026 with their futuristic G1 autonomous mower. This isn't just another piece of lawn equipment; it's practically a tech marvel on wheels, weaving together LiDAR, AI Vision, RTK, and 4G tech to make it the ultimate multitasker for the landscaping industry. We're talking obstacle...

Continue Reading
Tam-Peli Steps Up in SCLC Battle: Trial Insights

Updated Category News Views 5

Noteworthy Developments in Small-Cell Lung Cancer Treatment Let's dive into a story straight from the world of small-cell lung cancer (SCLC) that doesn't take any prisoners. The antidote making waves is tambotatug pelitecan, or Tam-Peli for short, showcasing its might in the unrelenting fight against relapsed SCLC. The phase III TAISHAN-302 trial puts Tam-Peli...

Continue Reading

Top 5 Most Recently Viewed Articles

HeartCore's Journey: From Nasdaq Challenges to Growth Potential

Updated Category News Views 35

HeartCore's Nasdaq Delisting Challenge HeartCore Enterprises, Inc. (NASDAQ:HTCR), a provider of enterprise software and consulting services, is currently facing a significant challenge related to its listing on the Nasdaq Capital Market. The company has received notice of non-compliance with the minimum bid price requirement, which mandates that its stock price must be at...

Continue Reading
Mitchell Capital Expands Portfolio with Optelos Acquisition

Updated Category News Views 236

Mitchell Capital's New Acquisition of Optelos Mitchell Capital, a prominent private equity firm, recently announced a significant acquisition that marks a pivotal moment for their long-term investment strategy. They have secured a controlling interest in Optelos, a distinguished provider of digital twin platforms that are tailored for enhancing critical infrastructure...

Continue Reading
Tampa Bay Lightning and Scripps Sports Forge Exciting Partnership

Updated Category News Views 247

Partnership Announcement Between Tampa Bay Lightning and Scripps Sports The Tampa Bay Lightning have officially entered into an exciting multi-year partnership with Scripps Sports. This collaboration signifies a new chapter for the Tampa Bay Lightning, expanding their reach in broadcasting and enhancing viewer engagement with National Hockey League (NHL) games. Through...

Continue Reading
Kazia Therapeutics Sets Meeting with FDA on Glioblastoma Treatment

Updated Category News Views 61

Kazia Therapeutics Prepares for FDA Meeting on Paxalisib Kazia Therapeutics Limited (NASDAQ: KZIA), an oncology-focused drug development company, is set to meet with the U.S. Food and Drug Administration (FDA) to explore potential pathways for the registration of its innovative drug, Paxalisib, aimed at treating newly diagnosed glioblastoma multiforme (GBM). This crucial...

Continue Reading
Important Notice for Flux Power Investors on Lead Plaintiff Claims

Updated Category News Views 100

Overview of Flux Power Investor Claims Investors with concerns regarding their investments in Flux Power Holdings, Inc. (NASDAQ: FLUX) have much to consider as recent developments unfold. The national securities law firm, Faruqi & Faruqi, LLP, is actively investigating claims that could impact investor interests and is eager to assist those affected. Critical Investment...

Continue Reading